Table 5.
ηp2 | Unifactorial part. Eta2 for changes (interaction)* | Main effect | Unifactorial part. Eta2 for performance scores** | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Between-factors | Sex | Age | ICD | BMI | IT | Pre MQO | Time | Sex | Age | ICD | BMI | IT | Pre MQO | |||
Outcome measures | f/m | 3-stage | 6-stage | 3-stage | 3-stage | 3-stage | 2-stage | f/m | 3-stage | 6-stage | 3-stage | 3-stage | 3-stage | |||
CROM (1) | FTF | 0.000 | 0.001 | 0.010 | 0.041*** | 0.008 | 0.182*** | 0.328*** | 0.016* | 0.009 | 0.008 | 0.033** | 0.004 | 0.222*** | ||
PROMs (6) | EQ5D Health (EQ-VAS) | 0.000 | 0.006 | 0.009 | 0.002 | 0.001 | 0.007 | 0.059*** | 0.001 | 0.017* | 0.015 | 0.001 | 0.005 | 0.044*** | ||
EQ5D TTO | 0.003 | 0.008 | 0.001 | 0.009 | 0.007 | 0.010 | 0.133*** | 0.001 | 0.004 | 0.003 | 0.024** | 0.035** | 0.066*** | |||
NPRS | 0.001 | 0.003 | 0.012 | 0.006 | 0.003 | 0.019* | 0.251*** | 0.002 | 0.004 | 0.012 | 0.013 | 0.020* | 0.045*** | |||
HAQ | 0.000 | 0.003 | 0.007 | 0.015 | 0.008 | 0.005 | 0.058*** | 0.011* | 0.040*** | 0.008 | 0.018* | 0.030** | 0.187*** | |||
ODI | 0.011* | 0.003 | 0.001 | 0.004 | 0.001 | 0.006 | 0.230*** | 0.002 | 0.006 | 0.004 | 0.012 | 0.030** | 0.140*** | |||
Mean PROMs | 0.003 | 0.002 | 0.004 | 0.009 | 0.005 | 0.008 | 0.302*** | 0.005 | 0.016* | 0.009 | 0.021* | 0.043** | 0.150*** | |||
overall MQO | PROMs and CROM-FTF | 0.001 | 0.000 | 0.007 | 0.017* | 0.001 | 0.124*** | 0.472*** | 0.001 | 0.017* | 0.010 | 0.027** | 0.024* | 0.290*** | ||
Consistency | Difference CROM − PROMs | 0.002 | 0.003 | 0.006 | 0.029** | 0.013 | 0.042*** | 0.009 | 0.022** | 0.008 | 0.006 | 0.024** | 0.034** | 0.003*** |
Sex (female, male); age (< = 50, 51–60, 61 +); ICD…six main-diagnoses (n > 30; M51.1, M51.2, M53.9, M54.4, M54.9, other LBG); BMI…Body Mass Index (< = 25, 25–30, 30 +); IT… Individual therapy minutes (< = 360, 361–450, 451 +); pre…pre-rehabilitation value of MQO (tertile)
A part. Eta2 (ηp2) between 0.01 and 0.06 corresponds to a small effect, occurrences of 0.06–0.14 a middle effect and values > 0.14 a large effect; level of significance (bold): *p < 0.05, **p < 0.01, ***p < 0.001; N = 395 LBP patients
*Differences (improvements; post − pre) from admission to discharge (corresponds to the interaction: time x between-factor)
**Performance Scores: t2D = t2z + (t2z − t1z)
Performance scores were much more sensitive to the individual factors compared to the difference scores. The factors sex and age showed significant effects in performance scores. In addition to initial values (all p < 0.001; overall MQO: ηp2 = 0.290), the BMI had the greatest influence on the performance evaluation (ηp2 = 0.027, p < 0.01). The amount of individual therapy (IT) depends on the medical history, if the rehabilitation program is classified as follow-up treatment procedure after surgery (IT > 450 min)